How is the Elicio Therapeutics Inc. today?

The Elicio Therapeutics Inc. today is trading in the green, up by 4.26% at 8.08.

What is Elicio Therapeutics Inc. Annual Net Profit?

Elicio Therapeutics Inc. Annual Net Profit fell 47.46% in the last year to $51.9 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Elicio Therapeutics Inc. Price to Earning Ratio?

Elicio Therapeutics Inc. Price to Earning Ratio is -2.52, which is negative.

What is Elicio Therapeutics Inc. Stock Price?

Elicio Therapeutics Inc. Stock Price rose 2.28% and underperformed its sector by 24.26% in the past year.

What is Elicio Therapeutics Inc. Quarterly Net profit?

Elicio Therapeutics Inc. Quarterly Net profit rose 5.23% YoY to $11.21 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Elicio Therapeutics Inc. Return on Equity(ROE)?

Elicio Therapeutics Inc. Return on Equity(ROE) for the last financial year was -170,157.38%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Elicio Therapeutics Inc. Mutual Fund Holding?

Elicio Therapeutics Inc. Mutual Fund Holding increased by 0.54% in the last quarter to 4.91.

What is Elicio Therapeutics Inc. Interest Coverage Ratio?

Elicio Therapeutics Inc. Interest Coverage Ratio is -113.06, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Elicio Therapeutics Inc. Institutional Holding?

Elicio Therapeutics Inc. Institutional Holding increased by 6.22% in the last quarter to 9.53.

Elicio Therapeutics Inc. XNAS: ELTX

Elicio Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Elicio Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Elicio Therapeutics Inc.
Rating: 1.58000
Author: Trendlyne DVM scores

about

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigationa...

8.08 0.33 (4.26%)

141.92% Gain from 52W Low

65,582 XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Moderately Bullish

63.2 / 100

No estimates available

Elicio Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Elicio Therapeutics Inc. FAQ

How is Elicio Therapeutics Inc. today?

Elicio Therapeutics Inc. today is trading in the green, and is up by 4.26% at 8.08.

How has Elicio Therapeutics Inc. performed historically?

Elicio Therapeutics Inc. is currently trading up 4.26% on an intraday basis. In the past week the stock rose 42.76%. stock has been down -2.77% in the past quarter and rose 2.28% in the past year. You can view this in the overview section.